EUVIMEDAtrasti EUVIMED
Crossref

Patch testing in non‐immediate hypersensitivity to cotrimoxazole: Is it useful?

João Nuno Soares iD, João Pedro Teixeira, Ana Carolina Figueiredo, André Castro Pinho, Margarida Gonçalo iD

Contact Dermatitis · 2024-12 · 91 (6) · 503-505

DOI: 10.1111/cod.14692 ↗

At a glance

Journal article in Contact Dermatitis, published online on 2024-09-04. Written by João Nuno Soares and 4 co-authors. Institution: Dermatology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal. Major MEDLINE topics: Patch Tests, Trimethoprim, Sulfamethoxazole Drug Combination. Cited 7 times so far (Crossref); 13 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Existing literature has questioned the sensitivity of patch testing (PT) with cotrimoxazole (CTX) in the study of drug hypersensitivity.

Objectives

Assess the sensitivity of PT with CTX in non‐immediate cutaneous adverse drug reactions (CADR). Patients/Materials/Methods Retrospective analysis (2000–2022) of PT with an antibiotic series including CTX 10% pet (Chemotechnique Diagnostics©) performed according to ESCD guidelines in patients with suspected non‐immediate CADR reactions to CTX. Some patients were additionally tested with in‐house preparations of CTX from Bactrim DS® tablets at 10% in pet or water and trimethoprim 10% pet (Laboratórios Edol©).

Results

Sixty‐four patients (48F/16M; mean age 47 ± 18) were included, mostly with maculopapular exanthema (51, 80%). Notably, CTX was sole suspect in 24 patients. There was no positive reaction to CTX at 10% from Chemotechnique or Bactrim DS® tablets prepared at 10% pet for patch testing. One patient reacted exclusively to trimethoprim with 1+ reaction. Two patients had a faint reaction (1+) only with the powder of Bactrim DS® tablets in water at D2, but as the reactions faded completely in 24 or 48 h, they were interpreted as irritant non‐specific reactions.

Conclusion

These findings suggest that patch testing may lack sufficient sensitivity to diagnose CTX‐induced non‐immediate CADR. Therefore, clinicians should be cautious interpreting CTX patch test results.

Subjects

MeSH terms (MEDLINE)

Patch TestsTrimethoprim, Sulfamethoxazole Drug CombinationHumansFemaleMiddle AgedMaleRetrospective StudiesAdultAgedAnti-Bacterial AgentsDrug EruptionsSensitivity and Specificity

Author keywords

DRESSadverse drug reactionsantibioticcotrimoxazolecutaneousnon‐immediatepatch testing

Substances

Trimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial Agents

Authors and institutions

  • Dermatology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
  • Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal.

ORCID profiles: João Nuno Soares, Margarida Gonçalo

Cite

APA

Soares, J. N., Teixeira, J. P., Figueiredo, A. C., Pinho, A. C., & Gonçalo, M. (2024). Patch testing in non‐immediate hypersensitivity to cotrimoxazole: Is it useful?. Contact Dermatitis, 91(6), 503-505. https://doi.org/10.1111/cod.14692

Vancouver

Soares JN, Teixeira JP, Figueiredo AC, Pinho AC, Gonçalo M. Patch testing in non‐immediate hypersensitivity to cotrimoxazole: Is it useful?. Contact Dermatitis. 2024;91(6):503-505. doi:10.1111/cod.14692

BibTeX
@article{Soares2024,
  author = {Soares, João Nuno and Teixeira, João Pedro and Figueiredo, Ana Carolina and Pinho, André Castro and Gonçalo, Margarida},
  title = {Patch testing in non‐immediate hypersensitivity to cotrimoxazole: Is it useful?},
  journal = {Contact Dermatitis},
  year = {2024},
  volume = {91},
  number = {6},
  pages = {503--505},
  doi = {10.1111/cod.14692}
}
Start for free →